Published • loading... • Updated
The patent cliff is looming and CDMOs need to be prepared, Fujifilm CEO says
Summary by endpoints.news
2 Articles
2 Articles
An unprecedented wave of drug patents will expire in the coming years. A boon for generic and biosimilar laboratories. And an opportunity for savings for health systems.
·Paris, France
Read Full Article
The patent cliff is looming and CDMOs need to be prepared, Fujifilm CEO says
As drugmakers prepare for the looming biopharma patent cliff, 2026 has so far been a year for dealmaking. Now, contract manufacturers need to broaden their services to keep up, Fujifilm Biotechnologies CEO Lars Petersen told ...
Coverage Details
Total News Sources2
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
